| Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH) J Pidala, PA Carpenter, L Onstad, SZ Pavletic, BK Hamilton, GL Chen, ... Plos one 19 (5), e0298026, 2024 | | 2024 |
| High-dose Alemtuzumab-Cyclosporine vs Tacrolimus-Methotrexate-Sirolimus for Chronic Graft-versus-Host Disease Prevention NG Holtzman, LM Curtis, RB Salit, BC Shaffer, F Pirsl, A Ostojic, ... Blood Advances, bloodadvances. 2023010973, 2024 | | 2024 |
| Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease RK Rosenstein, JJ Rose, SR Brooks, WL Tsai, M Gadina, SZ Pavletic, ... JID Innovations 4 (2), 100246, 2024 | | 2024 |
| The evolution of preclinical models for myelodysplastic neoplasms A Mina, S Pavletic, PD Aplan Leukemia, 1-9, 2024 | | 2024 |
| Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions SJ Bracken, AN Suthers, RA DiCioccio, H Su, S Anand, JC Poe, W Jia, ... Blood Advances 8 (3), 667-680, 2024 | 2 | 2024 |
| Janus Kinase (JAK) 1 Inhibition Results in Significant Changes in Serum Proteins and Peripheral T-Cell Populations That Correlate with Clinical Scores in Patients with Chronic … M Pratta, A Volkova, M Bleam, R Morariu-Zamfir, B Rumberger, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Sclerotic Graft-Versus-Host Disease of the Torso As a Determinant of Pulmonary Function and Clinical Outcomes A Kapetanovic, F Pirsl, SM Steinberg, E Shulz, A Barochia, EW Cowen, ... Transplantation and Cellular Therapy 30 (2), S270, 2024 | | 2024 |
| Effector Site Immune Dynamics in Refractory Chronic Graft-Versus-Host Disease: A Rockstar Trial Companion Study after Belumosudil Treatment. R Sharma, NG Holtzman, I Pusic, C Cutler, N Treister, RS Mehta, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Belumosudil for Chronic Graft-Versus-Host Disease after 2 or More Prior Lines of Systemic Therapy: 3-Year Follow-up of the Rockstar Study SJ Lee, C Cutler, SZ Pavletic, BR Blazar Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study SA Mitchell, R Hunter, A Fry, SZ Pavletic, BC Widemann, L Wiener Frontiers in Psychology 14, 1243005, 2024 | | 2024 |
| Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease E Schulz, F Pirsl, NG Holtzman, D Beshensky, EW Cowen, SA Mitchell, ... Haematologica 109 (1), 298, 2024 | | 2024 |
| Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease AT Zhao, F Pirsl, SM Steinberg, NG Holtzman, E Schulz, A Mina, JW Mays, ... Bone Marrow Transplantation 58 (12), 1377-1383, 2023 | | 2023 |
| Preconditioning Single High-Dose Palifermin Alters the Posttransplant Inflammatory Cytokine Profile E Schulz, NG Holtzman, A Ostojic, F Pirsl, SM Steinberg, LM Curtis, ... Blood 142, 4788, 2023 | | 2023 |
| Janus Kinase (JAK) 1 Inhibition Results in Significant Changes in Serum Proteins and Peripheral T-Cell Populations That Correlated with Clinical Scores in Chronic Graft Versus … M Pratta, A Volkova, M Bleam, R Morariu-Zamfir, B Rumberger, ... Blood 142, 2197, 2023 | | 2023 |
| Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA Y Pang, TE Andargie, MK Jang, H Kong, W Park, T Hill, N Redekar, YP Fu, ... Iscience 26 (11), 2023 | 2 | 2023 |
| PREVALENCE AND FACTORS ASSOCIATED WITH METABOLIC SYNDROME IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE A Zhao, F Pirsl, S Steinberg, N Holtzman, E Schulz, A Mina, J Mays, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 302-303, 2023 | | 2023 |
| BRONCHIOALVEOLAR LAVAGE AND BLOOD BIOMARKERS SUPPORT TH2 UPREGULATION IN BOS AFTER HCT M Qayed, S Pavletic, N Holtzman, F Hakim, J Switchenko, J Rose, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 287-288, 2023 | | 2023 |
| Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease D Beshensky, F Pirsl, NG Holtzman, SM Steinberg, JW Mays, EW Cowen, ... Bone Marrow Transplantation 58 (10), 1112-1120, 2023 | | 2023 |
| W “HY” antigen/HLA complexes in chronic GVHD NG Holtzman, SZ Pavletic Blood 142 (11), 946-948, 2023 | | 2023 |
| Chronic GvHD NIH consensus project biology task force: Evolving path to personalized treatment of chronic GvHD NP Buxbaum, G Socié, GR Hill, KPA MacDonald, V Tkachev, T Teshima, ... Blood Advances 7 (17), 4886-4902, 2023 | 7 | 2023 |
